A337840 Stock Overview
UXN Co., Ltd. develops and produces Gluco-Chaser, a continuous glucose monitoring system for managing type-I and type-II diabetes; and Always continuous glucose monitoring sensors.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
UXN Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,850.00 |
| 52 Week High | ₩30,900.00 |
| 52 Week Low | ₩13,480.00 |
| Beta | 0 |
| 1 Month Change | -9.83% |
| 3 Month Change | -13.27% |
| 1 Year Change | -23.35% |
| 3 Year Change | -47.64% |
| 5 Year Change | n/a |
| Change since IPO | 53.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| A337840 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -3.1% | 1.5% | 2.7% |
| 1Y | -23.4% | 29.8% | 5.8% |
Return vs Industry: A337840 underperformed the KR Medical Equipment industry which returned 29.8% over the past year.
Return vs Market: A337840 underperformed the KR Market which returned 5.8% over the past year.
Price Volatility
| A337840 volatility | |
|---|---|
| A337840 Average Weekly Movement | 3.2% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A337840 has not had significant price volatility in the past 3 months.
Volatility Over Time: A337840's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Sejin Park | uxn.co.kr |
UXN Co., Ltd. develops and produces Gluco-Chaser, a continuous glucose monitoring system for managing type-I and type-II diabetes; and Always continuous glucose monitoring sensors. The company was founded in 2012 and is based in Suwon-si, South Korea.
UXN Co., Ltd. Fundamentals Summary
| A337840 fundamental statistics | |
|---|---|
| Market cap | ₩51.36b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A337840 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A337840 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A337840 perform over the long term?
See historical performance and comparison